AIP
PYXS icon

Ameritas Investment Partners’s Pyxis Oncology PYXS Stock Holding History

Ameritas Investment Partners’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,784
Closed -$4.69K – 3310
2025
Q1 		$4.69K Hold
4,784
– – ﹤0.01% 2986
2024
Q4 		$7.46K Hold
4,784
– – ﹤0.01% 2972
2024
Q3 		$17.6K Hold
4,784
– – ﹤0.01% 2714
2024
Q2 		$15.8K Buy
+4,784
New +$20.1K ﹤0.01% 2719
2022
Q2 		– Sell
-822
Closed -$3K – 3200
2022
Q1 		$3K Hold
822
– – ﹤0.01% 3031
2021
Q4 		$9K Buy
+822
New +$9.41K ﹤0.01% 2929

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's PYXS Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 4,784 shares — an estimated $4.69K sold.

Ameritas Investment Partners first reported a position in PYXS in Q4 2021 and held it in 6 quarters. The position peaked at $17.6K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,784 Pyxis Oncology shares in Q2 2025, an estimated $4.69K.
  • Ameritas Investment Partners first reported a position in Pyxis Oncology in Q4 2021 and held it in 6 quarters.
  • Ameritas Investment Partners's Pyxis Oncology position peaked at $17.6K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.